Anti-Human C5 Recombinant Antibody(Eculizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human C5 Recombinant Antibody(Eculizumab)

Anti-Human C5 Recombinant Antibody(Eculizumab)

产品编号

YR1003

别名

科研级 Eculizumab ( 依库珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Eculizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Eculizumab ( 依库珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Eculizumab
Catalog Number	YR1003
Molecular Name	Eculizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2-G4 Kappa
Formulation	PBS, pH7.5
Background	Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death.
CAS Number	219685-50-4
Application	ELISA, FCM, IP, FuncS, IF, Neut
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	148 kDa
Target	C5[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0